The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CAESAREA, Israel--(BUSINESS WIRE)--V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced today the results of its first human ...

Johnson & Johnson announced the acquisition of heart disease medical device maker V-Wave in a deal worth up to $1.7 billion. Announced Tuesday, the transaction involves J&J paying $600 million upfront ...

Johnson & Johnson announced Aug. 20 it entered into a definitive agreement to acquire V-Wave Ltd., a privately held company that develops treatment options for heart failure. Under the terms of the ...

A novel percutaneously implanted unidirectional shunt for the treatment of systolic HF showed promising safety and efficacy outcomes at 3 months, according to new findings presented at TCT 2015. The ...

CAESAREA, Israel and AGOURA HILLS, California, March 5, 2020 /PRNewswire/ -- V-Wave Ltd., a privately held medical device company developing novel implantable devices for the treatment of Heart ...

Johnson & Johnson (J&J) aims to add a fourth cardiac business to its portfolio in less than two years with the acquisition of V-Wave Ltd., which makes the Ventura interatrial shunt system for the ...

US-based pharmaceutical company Johnson & Johnson said Tuesday that it will acquire V-Wave, a medical device company focusing on patients with heart failure, for up to $1.7 billion. The agreement ...

Johnson & Johnson announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart ...